There's actually some human data on lopinavir/ritonavir for #coronavirus A case study where all 4 patients received the combo, 2 discharged home and 2 still in the hospital. But it's a case series. What would have happened without the drug? https://t.co/rq4saAE4uf
Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Feb 2020 – Jan 2021Where it's discussed
-
X / Twitter9 posts
-
YouTube4 videos
-
Blogs2 articles
AI synopsis
What people are saying
Several discussions highlight the combination of Chinese and Western medicine as a promising approach, mentioning specific treatments like SFJDC and lopinavir/ritonavir, with words like 'appears to have some activity' and 'case series' indicating cautious optimism and interest in clinical outcomes. The overall tone reflects curiosity and recognition of potential therapeutic value, though with acknowledgment that more research is still needed.
Most discussions acknowledge the potential benefits of combining Chinese and Western treatments, though some remark that further research is needed, indicating cautious support.
The posts demonstrate moderate interest by highlighting the novelty of combining traditional and modern medicine approaches to COVID-19 treatment.
Comments include referencing specific medicines like SFJDC and antiviral drugs, showing a moderate level of detailed engagement with the study's content.
The focus on clinical cases and potential therapeutic benefits suggests these discussions recognize a meaningful impact in the ongoing search for effective COVID-19 treatments.
Abstract in brief
- The study reports on four COVID-19 pneumonia patients treated with a combination of Chinese and Western medicines, including antivirals like lopinavir/ritonavir and arbidol, along with traditional Chinese medicine (SFJDC), showing varying levels of clinical improvement.
- Three patients with mild symptoms showed significant recovery and were discharged, with two testing negative for the virus; one patient with severe pneumonia also showed signs of improvement.
- The findings suggest that this combined treatment approach might be beneficial, but further research is needed to confirm the effectiveness of the antivirals and traditional medicine used.]
Top posts
Most liked on X and BlueskyTrending on PubMed: Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment. https://t.co/8pk2hcCetM
Clinical Characteristics and Therapeutic Procedure for Four Cases With 2019 Novel Coronavirus Pneumonia Receiving Combined Chinese and Western Medicine Treatment - PubMed https://t.co/ZwL9JWzdcY
Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medi... - PubMed - NCBI https://t.co/SpvDn1PlZH
All mentions
Combined Chinese and Western Medicine Treatment for COVID-19 Pneumonia
The study reports on four COVID-19 patients treated with a combination of Chinese and Western medicines, including antivirals and traditional Chinese medicine, showing varied clinical improvements and suggesting…
Combined Chinese and Western Medicine Treatment for COVID-19 Pneumonia
This video discusses a study on four COVID-19 patients treated with combined Chinese and Western medicines, showing potential benefits and clinical improvements, highlighting the need for further research to confirm…
Evaluating Combined Chinese and Western Medicine Treatment for COVID-19 Pneumonia
This video discusses a study of four COVID-19 pneumonia patients treated with a combination of Chinese and Western medicines, including antivirals and traditional Chinese medicine, showing different levels of…
Combined Chinese and Western Medicine in COVID-19 Treatment
This video discusses the clinical characteristics and treatment approaches for COVID-19 pneumonia using a combination of Chinese and Western medicines, highlighting patient outcomes and potential benefits of integrated…
The #chinese medicine Shufeng Jiedu Capsule (SFJDC) appears to have some activity against #covid19 in combination with lopinavir/ritonavir (Kaletra®), and Russian antiviral arbidol #coronavirus #covidmune https://t.co/kL6taFsrNN
Clinical Characteristics and Therapeutic Procedure for Four Cases With 2019 Novel Coronavirus Pneumonia Receiving Combined Chinese and Western Medicine Treatment - PubMed https://t.co/ZwL9JWzdcY
There's actually some human data on lopinavir/ritonavir for #coronavirus A case study where all 4 patients received the combo, 2 discharged home and 2 still in the hospital. But it's a case series. What would have happened without the drug? https://t.co/rq4saAE4uf
Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medi... - PubMed - NCBI https://t.co/SpvDn1PlZH
Trending on PubMed: Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment. https://t.co/8pk2hcCetM
Trend new: *Wang Z* et al (Biosci Trends) __Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment__ https://t.co/KBiWsiIDgO
New article: Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment. https://t.co/OqhnKsF9Jg #coronavirus #wuhan #2019ncov